financetom
Business
financetom
/
Business
/
Union 'Salts' Stir The Pot As Starbucks Ramps Up Hiring
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Union 'Salts' Stir The Pot As Starbucks Ramps Up Hiring
Jun 26, 2025 10:53 AM

Starbucks Corp. ( SBUX ) is reportedly navigating heightened union tensions as Workers United launches a bold initiative encouraging labor organizers to apply for barista roles.

The union’s move coincides with Starbucks’ plans to bolster store staffing, potentially turning the company’s hiring spree into an unexpected organizing opportunity, Financial Times reports.

Through a public campaign on social media, Workers United is recruiting “salts”—activists who seek employment with the aim of organizing from within.

Also Read: Starbucks Denies Full China Exit Amid Stake Sale Talks As Market Share Slips To 14%

The initiative comes as the union has successfully won elections at 600 of Starbucks’ more than 10,300 U.S. company-operated locations,

Starbucks ( SBUX ) executives recently acknowledged that prior staffing cuts weakened customer service. They subsequently announced a plan to expand headcount starting in August.

Last month, the union posted a call for applicants to join a new program that would assist them in landing jobs and organizing efforts from inside the cafés.

This open recruitment for salting reflects a strategic escalation and comes amid ongoing—but tense—contract negotiations with Starbucks ( SBUX ). Walkouts over a new dress code last month underscored the strained relationship.

Starbucks ( SBUX ) criticized the union’s recruitment campaign, urging it to redirect energy toward finalizing a contract.

Sara Kelly, Starbucsk Chief Partner Officer, noted that more than 30 tentative agreements had been reached. She also warned against using resources to insert outside organizers, Financial Times adds.

Cornell labor expert Kate Bronfenbrenner explained that publicizing salting efforts signals sustained union pressure and intent to continue organizing efforts regardless of company resistance.

Meanwhile, Starbucks ( SBUX ) is denying reports it is considering a full exit from China. A spokesperson told Reuters the company isn't pursuing a full sale.

The Seattle-based company reportedly initiated a formal sale process in May, with Goldman Sachs advising.

Price Action: SBUX shares are trading lower by 0.48% to $90.62 at last check Thursday.

Read Next:

Meta Secures More Clean Energy For Power Hungry AI And Data Center Growth

Image: Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
RKD Group Acquires Whiteboard
RKD Group Acquires Whiteboard
Jul 27, 2026
Premier Marketing Agency Bolsters Conceptual Creative Capabilities by Acquiring Award-Winning Agency PLANO, Texas, July 27, 2026 /PRNewswire/ -- Today, RKD Group, North America's fundraising and marketing services firm supporting mission-driven organizations, announced its acquisition of Whiteboard. Founded in 1970, RKD Group serves over 250 enterprises across healthcare, disease research, social services, animal welfare, faith-based causes, education, humanitarian relief, and more....
Form 8.3
Form 8.3
Jul 27, 2026
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Medicus Pharma Gets FDA Approval to Advance Phase 2b SkinJect Study
Medicus Pharma Gets FDA Approval to Advance Phase 2b SkinJect Study
Jul 27, 2026
08:41 AM EDT, 07/27/2026 (MT Newswires) -- Medicus Pharma ( MDCX ) said Monday that the US Food and Drug Administration issued a Study May Proceed letter for its Investigational New Drug application, allowing the company to begin an NDA-enabling Phase 2b SkinJect study in patients with Gorlin Syndrome. The SKNJCT-005 study will evaluate SkinJect 200 mcg in up to...
Argo Closes C$10 Million Private Placement
Argo Closes C$10 Million Private Placement
Jul 27, 2026
08:42 AM EDT, 07/27/2026 (MT Newswires) -- Argo (ARGH.V) raised C$10 million after closing a private placement with long-term institutional investors, the public transit solutions provider said Monday. Argo said it plans to use the proceeds to fund expansion plans in the US and Canada, fund research and development, and for working capital and general corporate purposes. Under the offering,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved